Cargando…

Memory markers in the continuum of the Alzheimer’s clinical syndrome

BACKGROUND: The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCSRT would...

Descripción completa

Detalles Bibliográficos
Autores principales: Parra, Mario A., Calia, Clara, Pattan, Vivek, Della Sala, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526252/
https://www.ncbi.nlm.nih.gov/pubmed/36180965
http://dx.doi.org/10.1186/s13195-022-01082-9
_version_ 1784800838987808768
author Parra, Mario A.
Calia, Clara
Pattan, Vivek
Della Sala, Sergio
author_facet Parra, Mario A.
Calia, Clara
Pattan, Vivek
Della Sala, Sergio
author_sort Parra, Mario A.
collection PubMed
description BACKGROUND: The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCSRT would inform on imminent progression. METHODS: Healthy older adults (n=70) and patients with mild cognitive impairment (MCI) (n=80) were recruited and followed up between 2012 and 2017. Participants with at least two assessment points entered the study. Using baseline and follow-up assessments four groups were defined: Older adults who were healthy (HOA), with very mild cognitive but not functional impairment (eMCI), and with MCI who did and did not convert to dementia (MCI converters and non-converters). RESULTS: Only the VSTMBT predicted group membership in the very early stages (HOA vs eMCI). As the disease progressed, the FCSRT became a strong predictor excluding the VSTMB from the models. Their complementary value was high during the mid-prodromal stages and decreased in stages closer to dementia. DISCUSSION: The study supports the notion that neuropsychological assessment for AD needs to abandon the notion of one-size-fits-all. A memory toolkit for AD needs to consider tools that are early indicators and tools that suggest imminent progression. The VSTMBT and the FSCRT are such tools. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01082-9.
format Online
Article
Text
id pubmed-9526252
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95262522022-10-02 Memory markers in the continuum of the Alzheimer’s clinical syndrome Parra, Mario A. Calia, Clara Pattan, Vivek Della Sala, Sergio Alzheimers Res Ther Research BACKGROUND: The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCSRT would inform on imminent progression. METHODS: Healthy older adults (n=70) and patients with mild cognitive impairment (MCI) (n=80) were recruited and followed up between 2012 and 2017. Participants with at least two assessment points entered the study. Using baseline and follow-up assessments four groups were defined: Older adults who were healthy (HOA), with very mild cognitive but not functional impairment (eMCI), and with MCI who did and did not convert to dementia (MCI converters and non-converters). RESULTS: Only the VSTMBT predicted group membership in the very early stages (HOA vs eMCI). As the disease progressed, the FCSRT became a strong predictor excluding the VSTMB from the models. Their complementary value was high during the mid-prodromal stages and decreased in stages closer to dementia. DISCUSSION: The study supports the notion that neuropsychological assessment for AD needs to abandon the notion of one-size-fits-all. A memory toolkit for AD needs to consider tools that are early indicators and tools that suggest imminent progression. The VSTMBT and the FSCRT are such tools. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01082-9. BioMed Central 2022-09-30 /pmc/articles/PMC9526252/ /pubmed/36180965 http://dx.doi.org/10.1186/s13195-022-01082-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Parra, Mario A.
Calia, Clara
Pattan, Vivek
Della Sala, Sergio
Memory markers in the continuum of the Alzheimer’s clinical syndrome
title Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_full Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_fullStr Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_full_unstemmed Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_short Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_sort memory markers in the continuum of the alzheimer’s clinical syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526252/
https://www.ncbi.nlm.nih.gov/pubmed/36180965
http://dx.doi.org/10.1186/s13195-022-01082-9
work_keys_str_mv AT parramarioa memorymarkersinthecontinuumofthealzheimersclinicalsyndrome
AT caliaclara memorymarkersinthecontinuumofthealzheimersclinicalsyndrome
AT pattanvivek memorymarkersinthecontinuumofthealzheimersclinicalsyndrome
AT dellasalasergio memorymarkersinthecontinuumofthealzheimersclinicalsyndrome